Dewey Steadman | Head, IR |
Martine Rothblatt | Chairperson, CEO |
Michael Benkowitz | President, COO |
Leigh Peterson | SVP, Product Development |
Patrick Poisson | EVP, Technical Operations |
Andreas Argyrides | Wedbush Securities |
Eun Yang | Jefferies |
Jessica Fye | JPMorgan |
Joseph Thome | Cowen & Company |
Good morning, and welcome to the United Therapeutics Corporation First Quarter 2022 Earnings Webcast. My name is Abby, and I will be your conference operator today. [Operator Instructions] And I will now turn the webcast over to Dewey Steadman, Head of Investor Relations at United Therapeutics.
Thanks, Abby, and good morning. It’s my pleasure to welcome you to the United Therapeutics Corporation First Quarter 2022 Earnings Webcast.